Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) relapses rapidly after the initial response to chemotherapy and shows drug-resistance. This study was to investigate the efficacy and safety of cellular immunotherapy (CIT) with autologous natural killer (NK), γδT, and cytokine-induced killer (CIK) cells as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiao, Cao, He, Chen, Xiao, Jin, Haofan, Liu, Ziling, Wang, Guanjun, Cai, Lu, Li, Dan, Niu, Chao, Tian, Huimin, Yang, Lei, Zhao, Yuguang, Li, Wei, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446113/
https://www.ncbi.nlm.nih.gov/pubmed/25968637
http://dx.doi.org/10.1186/s12967-015-0514-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446113/
https://www.ncbi.nlm.nih.gov/pubmed/25968637
http://dx.doi.org/10.1186/s12967-015-0514-0

Ejemplares similares